现在是新IBS范式的时机了
1Department of Hospital Medicine, Osher Center for Integrative Medicine, University of California, San Francisco, CA, USA.
Global advances in integrative medicine and health
|September 29, 2025
概括
刺激性肠综合征 (IBS) 的根本原因是细菌失生症,类似于Helicobacter pylori.
科学领域:
- 胃肠病学 胃肠病学
- 微生物学 微生物学
背景情况:
- 胃潰瘍病在歷史上被錯誤地歸因於心理因素.
- 杆菌的发现彻底改变了胃潰瘍疾病的治疗方法.
- 刺激性肠综合征 (IBS) 越来越多地与细菌失生症有关.
研究的目的:
- 为了突出H. pylori和IBS病因学的相似之处.
- 倡导IBS诊断和治疗的范式转变.
主要方法:
- 历史和当前医学文献的综述.
- 胃潰瘍疾病和IBS病變的比較分析.
主要成果:
- 杆菌是已确定的胃潰瘍疾病的原因.
- 压倒性的证据表明,细菌失生症是IBS的原因.
- 目前的IBS管理侧重于息治疗,而不是根本原因.
结论:
- 细菌失生症是IBS的根本原因.
- 需要在IBS管理中进行范式转变.
- 针对细菌失生症的诊断和治疗应该是IBS的标准.
相关概念视频
Irritable Bowel Syndrome I: Introduction
923
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
923
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
732
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
732
Irritable Bowel Syndrome III: Medical and Nursing Management
643
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
643
Drugs for Treatment of Diarrhea-Predominant IBS
634
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
634
Drugs for Treatment of Constipation-Predominant IBS
724
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
724
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
643
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
643


